Literature DB >> 7643963

Development and isoproterenol-induced regulation of adrenoceptor binding in cultured rat neocortical explants is seen only with the beta-1, not with the beta-2 subtype.

G J Boer1, A A Kellerman, R E Baker, P te Riele, M G Feenstra, M Botterblom, B H Erdtsieck-Ernste.   

Abstract

The presence and time-course of beta-adrenoceptor density in cultured explants of neocortex obtained from 6-day-old rat pups were investigated using a [125I]ICYP binding assay. A delayed, but more pronounced, increase in the receptor expression was observed as compared to the situation previously described in vivo. These changes only occurred for the beta 1-subtype of the receptor, whereas the beta 2-subtype binding remained constant up to 3 weeks in vitro. The delay of beta 1-adrenoceptor expression may be due to the incomplete presence of the proper maturational input, and the late enhancement of receptor expression to upregulation related to the absence in vitro of noradrenergic input. Decreased beta-adrenoceptor levels could be induced by chronic treatment of the beta-agonist isoproterenol (1 microM) introduced either for 3 or 13 days. Again, changes in density were found only for the beta 1-adrenoceptor binding sites. There is no reduction of receptor density following return to control conditions for 10 days after a 3-day treatment with isoproterenol, demonstrating the ability of this model to attain its final receptor density notwithstanding the developmental insult.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7643963     DOI: 10.1007/bf01694539

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  48 in total

1.  Morphology and distribution of neurons and glial cells expressing beta-adrenergic receptors in developing kitten visual cortex.

Authors:  Y Liu; W G Jia; A D Strosberg; M Cynader
Journal:  Brain Res Dev Brain Res       Date:  1992-02-21

2.  Postnatal alterations in beta-adrenergic receptor binding in rat brain regions after continuous prenatal exposure to propranolol via maternal infusion.

Authors:  E M Kudlacz; J R Spencer; T A Slotkin
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1991-02

3.  Lasting effects of early noradrenergic receptor occupation on brain noradrenaline turnover and on beta-receptors.

Authors:  G J Boer; M G Feenstra; B H Erdtsieck-Ernste; J A Gorter; M Mirmiran
Journal:  Dev Pharmacol Ther       Date:  1990

4.  Electrophysiological properties of neurons in neonatal rat occipital cortex slices grown in a serum-free medium.

Authors:  R E Baker; D Bingmann; J M Ruijter
Journal:  Neurosci Lett       Date:  1989-02-27       Impact factor: 3.046

5.  Trophic control of the ornithine decarboxylase/polyamine system in neonatal rat brain regions: lesions caused by 6-hydroxydopamine produce effects selective for cerebellum.

Authors:  C Lau; A Cameron; L Antolick; T A Slotkin
Journal:  Brain Res Dev Brain Res       Date:  1990-03-01

6.  Ontogeny of beta 1- and beta 2-adrenergic receptors in rat cerebellum and cerebral cortex.

Authors:  R N Pittman; K P Minneman; P B Molinoff
Journal:  Brain Res       Date:  1980-04-28       Impact factor: 3.252

7.  Expression of beta 2-adrenoceptors mediating cyclic AMP accumulation in astroglial and neuronal cell lines derived from the rat CNS.

Authors:  A Ruck; P Millns; D A Kendall; S J Hill
Journal:  Biochem Pharmacol       Date:  1990-11-15       Impact factor: 5.858

8.  Beta-adrenergic binding sites in fetal rat brain.

Authors:  A Bruinink; W Lichtensteiger
Journal:  J Neurochem       Date:  1984-08       Impact factor: 5.372

9.  Reversal of noradrenaline denervation-induced increase of beta-adrenoreceptor binding in rat neocortex by noradrenaline infusion.

Authors:  B Biswas; G Jonsson
Journal:  Eur J Pharmacol       Date:  1981-01-29       Impact factor: 4.432

10.  Effects of chronic antidepressant treatment on beta-adrenoceptor subtype binding in the rat cerebral cortex and cerebellum.

Authors:  P R Paetsch; A J Greenshaw
Journal:  Mol Chem Neuropathol       Date:  1993-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.